R-C8
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
None None SF_C387 None

SMILES:

Supramolecules

Namelog KSDpHT(°C)MethodRef
[a-Cyclodextrin](1).[R-C8] 1.20 0.48 7.0 25.0 NMR spectroscopy George W. Gokel 2003
[b-Cyclodextrin](1).[R-C8] 2.75 1.48 7.0 25.0 NMR spectroscopy George W. Gokel 2003
[Hexakis(2,3,6-tri-O-Methyl)-a-Cyclodextrin](1).[R-C8] 1.34 0.30 7.0 25.0 NMR spectroscopy George W. Gokel 2003
[Heptakis(2,3,6-tri-O-Methyl)-b-Cyclodextrin](1).[R-C8] 0.85 0.48 7.0 25.0 NMR spectroscopy George W. Gokel 2003

R-borneol
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
154.25 1 1 2.19 SF_C403 None Not checked

SMILES: CC1(C)C2(C)CCC1C[C@H]2O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[NC0-b-CD](1).[R-borneol] 5.32 7.0 25.0 Fluorescence spectroscopy Hiroshi Ikeda 2005
[NC4-b-CD](1).[R-borneol] 4.04 7.0 25.0 Fluorescence spectroscopy Hiroshi Ikeda 2005
[NC0-g-CD](1).[R-borneol] 3.86 7.0 25.0 Fluorescence spectroscopy Hiroshi Ikeda 2005

R-tryptophan
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
204.23 3 3 1.82 JN_400 None Not checked

SMILES: N[C@H](CC1=CNC2=C1C=CC=C2)C(O)=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[6A-(3-Aminopropylamino)-6A-deoxy-BCD complex with Cu2+](1).[R-tryptophan] 5.29 0.05 25.0 pH titration Stephen F. Lincoln 1994

R-tryptophan anion
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
203.22 2 2 0.49 JN_396 None Not checked

SMILES: N[C@H](CC1=CNC2=C1C=CC=C2)C([O-])=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[6A-(3-Aminopropylamino)-6A-deoxy-BCD complex with Co2+](1).[R-tryptophan anion] 4.04 0.03 25.0 pH titration Stephen F. Lincoln 1994
[6A-(3-Aminopropylamino)-6A-deoxy-BCD complex with Cu2+](1).[R-tryptophan anion] 7.85 0.07 25.0 pH titration Stephen F. Lincoln 1994
[6A-(3-Aminopropylamino)-6A-deoxy-BCD complex with Ni2+](1).[R-tryptophan anion] 4.10 0.20 25.0 pH titration Stephen F. Lincoln 1994

Randomly methylated-b-Cyclodextrin (DS ~12)
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
None None CY-2004.1 None

SMILES:

Supramolecules

Namelog KSDpHT(°C)MethodRef
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.49 7.2 15.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.41 7.2 20.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.33 7.2 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.26 7.2 30.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.14 7.2 40.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 2.61 2.0 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[fluoxetine] -2.36 7.2 20.0 J.J. Berzas 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[fluoxetine] -2.34 7.2 20.0 Benesi-Hildebrand method J.J. Berzas 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Cyproterone acetate] 3.77 25.0 phase solubility Sandrine Henry De Hassonville 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](2).[Cyproterone acetate] 1.28 25.0 phase solubility Sandrine Henry De Hassonville 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[indolinic nitroxide radical] 4.06 2.94 7.0 25.0 HPLC-method SANTO SCALIA 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Methyl orange] 4.20 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Eugenol] 2.72 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Isoeugenol] 2.74 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Benzyl alcohol] 1.74 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Anisyl alcohol] 2.10 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[6-(p-Toluidino)-2-naphthalenesulfonic acid] 3.92 2.30 9.0 Fluorescence spectroscopy A. Ruebner 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Zn-tri-t-butylphenoxy-mono-sulfophenoxy-phthalocyanine] 4.83 4.11 9.0 Fluorescence spectroscopy A. Ruebner 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[20(S)-Camptothecin] 2.20 1.7 25.0 HPLC-method Vijay Kumar 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Ro 28-2653] 4.44 7.0 37.0 HPLC-method Bertholet Pascal 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](2).[Ro 28-2653] 1.36 7.0 37.0 HPLC-method Bertholet Pascal 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[1 -anilinonaphthalene-8-sulfonate] 2.57 1.90 6.8 Fluorescence spectroscopy Brian D. Wagner 1998
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[chlorambucil] 3.55 2.72 7.35 40.0 HPLC-method Thorsteinn Loftsson 1998
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[chlorambucil] 3.94 2.91 4.15 37.0 UV spectroscopy Yannis L. Loukas 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[indomethacin] 2.89 1.95 9.8 40.0 HPLC-method Thorsteinn Loftsson 1998
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[diazepam] 2.15 1.70 2.0 30.5 HPLC-method Thorsteinn Loftsson 1998
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Carbon tetrachloride] 2.38 7.0 30.0 Solubility method, titration method Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Toluene] 2.23 7.0 30.0 Solubility method, titration method Sophie Fourmentin 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[insulin] 2.67 1.74 2.0 55.0 HPLC-method Yannis L. Loukas 2002
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naproxen] 3.84 5.0 25.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naproxen] 3.77 5.0 37.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naproxen] 3.71 5.0 45.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 4.06 4.5 25.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.98 4.5 37.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.17 5.5 25.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.04 5.5 37.0 UV-vis spectroscopy P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.43 4.5 37.0 Membrane permeation technique P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.98 5.5 25.0 Capillary electrophoresis P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Flurbiprofen] 3.87 5.5 37.0 Capillary electrophoresis P. Mura 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](2).[diflunisal] 1.94 1.43 7.0 25.0 NMR spectroscopy John H. Coates 1988
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[diflunisal] 4.84 2.30 7.0 25.0 UV-vis spectroscopy John H. Coates 1988
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 5.67 4.90 Fluorescence spectroscopy Athena Kasselouri 1999
[Randomly methylated-b-Cyclodextrin (DS ~12)](2).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 8.98 7.70 Fluorescence spectroscopy Athena Kasselouri 1999
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Pindolol] 2.04 1.08 12.0 25.0 HPLC-method Arantza Zornoza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[warfarin] 2.05 0.78 7.4 37.0 Fluorescence spectroscopy Serdar Ates 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[p-nitrophenol] 2.79 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[L-Phe ] 0.60 -0.30 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Gly-L-Phe ] 1.00 -0.10 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Gly-D-Phe ] 0.95 -0.15 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[L-PheGly ] 1.20 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[GlyGly-L-Phe ] 1.04 -0.05 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Gly-L-Tyr ] 1.11 -0.22 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[L-TrpGly ] 1.59 0.20 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Aspartame] 1.92 0.72 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[acitretin] 4.37 3.10 7.4 25.0 HPLC-method Paul C. Ho 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[acitretin] 2.20 1.45 9.0 25.0 HPLC-method Paul C. Ho 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[cannabidiol] 5.68 7.4 25.0 HPLC method Janne Mannila 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](0.5).[cannabidiol] 0.90 7.4 25.0 HPLC method Janne Mannila 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[∆9-tetrahydrocannabinol] 4.29 7.4 25.0 HPLC method Janne Mannila 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](0.5).[∆9-tetrahydrocannabinol] 1.60 7.4 25.0 HPLC method Janne Mannila 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[toluene] 2.34 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[toluene] 2.16 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[heptane] 2.60 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](0.5).[heptane] 3.23 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[cypermethrin] 3.00 7.0 20.0 UV-vis spectroscopy Judit Orgoványi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[tolfenamic acid] 2.19 7.0 25.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[tolfenamic acid] 1.91 7.0 30.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[tolfenamic acid] 1.87 7.0 37.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[tolfenamic acid] 1.62 7.0 45.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ketoprofen] 3.67 17.0 25.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ketoprofen] 3.44 18.0 30.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ketoprofen] 3.43 19.0 37.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ketoprofen] 3.32 20.0 45.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ketoprofen] 3.15 21.0 52.0 HPLC-method E. Antoniadou-Vyza 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[phenylbenzimidazole sulphonic acid] 1.96 0.32 4.0 25.0 HPLC-method Santo Scalia 2004
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naftifine] 3.05 1.46 12.0 25.0 UV-vis spectroscopy Itziar Velaz 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](2).[naftifine] 1.95 12.0 25.0 UV-vis spectroscopy Itziar Velaz 2006
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[methyl 2-[4-(2,4-dichlorophenoxy) phenoxy]propionate] 3.68 7.0 20.0 UV/VIS spectrometry, HPLC method Weiping Liu 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[iodine] 2.92 7.0 25.0 Sodium thiosulfate titration Lajos Szente 1999
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[nimodipine] 3.23 1.85 7.0 25.0 UV-vis spectroscopy Frantisek Kopecky 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[2,4,6-trichlorophenol] 2.45 3.0 24.0 UV-vis spectroscopy K. Hanna 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[2,4,6-trichlorophenol] 1.52 8.8 24.0 UV-vis spectroscopy K. Hanna 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naringenin] 3.00 4.0 25.0 UV-vis spectroscopy M. L. Calabro 2004
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[naringenin] 2.55 8.0 25.0 UV-vis spectroscopy M. L. Calabro 2004
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Nonanoic acid ] 4.00 3.00 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Decanoic acid ] 4.08 3.30 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Undecanoic acid ] 4.18 3.85 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Dodecanoic acid] 4.23 3.95 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Hexanoic acid] 1.53 0.95 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Heptanoic acid ] 2.43 1.00 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Octanoic acid ] 3.10 1.48 11.3 25.0 Calorimetry Giuseppina Castronuovo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[({2-[4-(4,6-diamino-[1,3,5]triazin-2-ylamino)-phenyl]-[1,3,2]dithiarsolan-4-yl}-methanol] 4.76 3.65 7.0 25.0 HPLC-method Stephane Gibaud 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[({2-[4-(4,6-diamino-[1,3,5]triazin-2-ylamino)-phenyl]-[1,3,2]dithiarsolan-4-yl}-methanol] 4.75 3.62 7.0 25.0 UV-vis spectroscopy Stephane Gibaud 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[4-nitrophenolate] 2.83 1.51 11.1 27.8 Capillary electrophoresis David M. Goodall 1995
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[methyl tert-butyl ether] 2.50 25.0 GC Ji-Won Yang 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[PBN] 1.90 0.85 27.0 NMR Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[PBNOH] 1.76 0.70 27.0 NMR Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[4-Me-PBNOH] 2.07 1.00 27.0 NMR Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[4-Et-PBNOH] 2.43 1.08 27.0 NMR Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of PBN] 2.92 ESR (EPR) Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of PBNOH] 3.01 ESR (EPR) Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of 4-Me-PBNOH] 2.61 ESR (EPR) Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[HOO˙ adduct of 4-Et-PBNOH] 2.99 ESR (EPR) Jean-Pierre Finet, Paul Tordo 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-hexane] 1.08 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-heptane] 2.05 1.40 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-octane] 1.90 0.85 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-nonane] 2.10 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-decane] 2.20 1.00 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-undecane] 2.12 1.26 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[n-dodecane] 1.82 1.08 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[cyclohexane] 2.68 0.90 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Me-cyclohexane] 2.57 0.60 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Et-cyclohexane] 2.87 1.46 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[benzene] 2.04 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[o-xylene] 2.35 0.60 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[m-xylene] 2.33 1.18 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[p-xylene] 2.48 1.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[Et-benzene] 2.51 1.95 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[1,3,5-trimethyl-benzene] 1.87 0.48 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[1,2,3-trimethyl-benzene] 2.35 1.45 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[1,2,4-trimethyl-benzene] 2.33 1.77 25.0 GC (SHSGC) É. Fenyvesi 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[3a,7a,12a-trihydroxy-5b-cholanoic acid] 3.43 1.40 25.0 Isothermal Titration Calorimetry Fredrik Ollila 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[3a,12a-dihydroxy-5b-cholanoic acid] 3.80 2.21 25.0 Isothermal Titration Calorimetry Fredrik Ollila 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[N-[3a,7a,12a-trihydroxy-24-oxocholan-24-yl]glycine] 2.98 2.25 25.0 Isothermal Titration Calorimetry Fredrik Ollila 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[2-[(3a,7a,12a-trihydroxy-24-oxo-5b-cholan-24-yl) amino]ethanesulfonic acid ] 3.33 1.52 25.0 Isothermal Titration Calorimetry Fredrik Ollila 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[xanthone] 3.48 2.30 20.0 fluorescence spectroscopy Cornelia Bohne 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[xanthone] 1.56 0.60 25.0 absorption spectroscopy Cornelia Bohne 2001
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[4-[(1-methyl-4(1H)-pyridinylidene)-ethylidene]-2,5-cyclohexadien-1-one] 2.11 0.54 8.0 25.0 UV-Vis spectroscopy Clodoaldo Machado 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[2,6-diphenyl-4-(2,4,6-triphenylpyridinium-1-yl)phenolate] 1.39 0.69 8.0 25.0 UV-Vis spectroscopy Clodoaldo Machado 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[haloperidol] 3.37 7.0 27.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[haloperidol] 3.13 7.0 37.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[haloperidol] 3.01 7.0 47.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[haloperidol] 2.81 7.0 57.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[ricobendazole] 2.23 differential scanning calorimetry Natalie J. Medlicott 2005
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[pindolol] 2.29 12.1 17.0 spectrofluorimetry Miguel Sanchez 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[pindolol] 2.27 12.1 20.0 spectrofluorimetry Miguel Sanchez 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[pindolol] 2.26 12.1 25.0 spectrofluorimetry Miguel Sanchez 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[pindolol] 2.24 12.1 30.0 spectrofluorimetry Miguel Sanchez 2003
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[fenoxaprop-p-ethyl] 3.62 6.0 25.0 differential scanning calorimetry, infrared spectroscopy, X-ray diffraction Weiping Liu 2005

Rhodamine B
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
479.01 4 1 3.93 NT_a0006 None Not checked

SMILES: [Cl-].CCN(CC)c1ccc2c(c1)[o+]c3cc(ccc3c2c4ccccc4C(O)=O)N(CC)CC

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[Rhodamine B] 3.46 Flamigni, Lucia 1993
[b-Cyclodextrin](1).[Rhodamine B] 3.77 25.0 Kenneth A. Connors 1995
[b-Cyclodextrin](1).[Rhodamine B] 3.63 7.2 25.0 Fluorescence spectroscopy Yu Liu 2001

Rhodamine B
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
479.01 4 1 3.93 nt1762 None Not checked

SMILES: [Cl-].CCN(CC)c1ccc2c(c1)[o+]c3cc(ccc3c2c4ccccc4C(O)=O)N(CC)CC

Supramolecules

Namelog KSDpHT(°C)MethodRef

Rhodamine B
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
479.01 4 1 3.93 nt1763 None Not checked

SMILES: [Cl-].CCN(CC)c1ccc2c(c1)[o+]c3cc(ccc3c2c4ccccc4C(O)=O)N(CC)CC

Supramolecules

Namelog KSDpHT(°C)MethodRef

Rhodamine B
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
479.01 4 1 3.93 nt1988 None Not checked

SMILES: [Cl-].CCN(CC)c1ccc2c(c1)[o+]c3cc(ccc3c2c4ccccc4C(O)=O)N(CC)CC

Supramolecules

Namelog KSDpHT(°C)MethodRef
[g-Cyclodextrin](1).[Rhodamine B] 1.85 25.0 Kenneth A. Connors 1995

Rhodamine B
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
479.01 4 1 3.93 SF_C1817 None Not checked

SMILES: [Cl-].CCN(CC)c1ccc2c(c1)[o+]c3cc(ccc3c2c4ccccc4C(O)=O)N(CC)CC

Supramolecules

Namelog KSDpHT(°C)MethodRef
[2,2'-Bipyridine-4,4'-dicarboxy-bridged bis(6-O-b-cyclodextrin)](1).[Rhodamine B] 4.43 7.2 25.0 Fluorescence spectroscopy Yu Liu 2001
[N,N'-bis(2-aminoethyl)-2,2'-bipyridine-4,4'-dicarboxamidebridged bis(6-amino-6-deoxy-b-cyclodextrin)](1).[Rhodamine B] 3.99 7.2 25.0 Fluorescence spectroscopy Yu Liu 2001
[N,N'-bis(5-amino-3-azapentyl)-2,2'-bipyridine-4,4'-dicarboxamidebridged bis(6-amino-6- deoxy-b-cyclodextrin)](1).[Rhodamine B] 3.67 7.2 25.0 Fluorescence spectroscopy Yu Liu 2001
[N,N'-bis(8-amino-3,6-diazaoctyl)-2,2'-bipyridine-4,4'-dicarboxamidebridged bis(6-amino-6-deoxy-b-cyclodextrin)](1).[Rhodamine B] 4.12 7.2 25.0 Fluorescence spectroscopy Yu Liu 2001